← Back to declarations

OPHLF Ono Pharmaceutical Co., Ltd. — dividend yield, history & ex-dividend dates

Other OTC· Semi-Annual dividend· Common Stock · Healthcare / Drug Manufacturers - General

$14.10 ▼ $-1.90(-11.88%) as of Oct 30, 2026 06:20 UTC
Sponsored Advanced charts & data →

Globally, Ono Pharmaceutical Co., Ltd., along with its affiliated entities, is engaged in the development, procurement, and commercialization of pharmaceutical products and diagnostic tools. Its product line features a wide array of therapeutic solutions, including several key oncology treatments such as OPDIVO, KYPROLIS, MEKTOVI, VELEXBRU, ADLUMIZ, and BRAFTOVI. It also offers EMEND and PROEMEND for managing chemotherapy-induced nausea and vomiting, and DEMSER for pheochromocytoma symptoms. For metabolic health, GLACTIV and FORXIGA target type 2 diabetes. The company provides medications for cardiovascular conditions (ONOACT for tachyarrhythmia, OPALMON for peripheral circulatory disorder, CORALAN for chronic heart failure) and autoimmune diseases (ORENCIA for rheumatoid arthritis). Neurological disorders are addressed with RIVASTACH for Alzheimer's and ONGENTYS for Parkinson's disease. Other significant offerings cover conditions such as overactive bladder (STAYBLA), bronchial asthma and allergic rhinitis (ONON), osteoporosis (RECALBON), and joint function improvement (JOYCLU), alongside PARSABIV for dialysis patients. Beyond its existing portfolio, the company maintains an active research and development pipeline, focusing on numerous therapeutic areas. This includes a broad spectrum of oncological conditions, such as various carcinomas (esophageal, urothelial, ovarian, bladder, prostate, hepatocellular, pancreatic, biliary tract, gastric, thyroid, colorectal, non-small cell lung), lymphomas (Hodgkin's, primary central nervous system), melanoma, acute myeloid leukemia, myelodysplastic syndrome, and virus-positive/negative solid tumors. Its developmental efforts also extend to inflammatory and autoimmune disorders like polymyositis/dermatomyositis, pemphigus, generalized scleroderma, and enthesopathy, as well as cardiovascular issues (tachyarrhythmia, thrombosis), neurodegenerative diseases, diabetic polyneuropathy, and conditions such as narcolepsy. Established in 1717, this long-standing enterprise operates from its main office in Osaka, Japan.

Dividend Snapshot

StatusRecently Increased
Last Dividend$0.2544
Forward Annual$0.51From the $0.2544 dividend declared May 08, 2026
FrequencySemi-Annual
Last Ex-DateSep 30, 2026The most recent ex-dividend date that has already passed.
1-Yr Growth-1.2%Annual totals, 2024–2025
10-Yr Growth6.0%Annual totals, 2015–2025

Research Scores

Scores describe this security's published financial data on a 0–100 scale using the formulas on our methodology pages. They are the same for every reader, are not a probability or a forecast, and are not a recommendation. Past dividend growth does not guarantee future increases. Report a data error.

Dividend Safety Score

98/100

Very strong indicators

Complete data

Dividend Growth Score

53/100

Moderate growth record

Complete data

Dividend Value Score

Not Rated

only 40% of the inputs available (60% needed)

DividendRank

70/100

Upper middle of the scale

Partial data

How the Dividend Safety Score is built for OPHLF
Dividend Safety Score inputs, points and weights
InputValuePointsWeight
Earnings payout ratioEarnings payout ratio 49% (TTM to Jun 30, 2026) 91 20%
FCF payout ratioFCF payout ratio 29% (TTM to Jun 30, 2026) 100 25%
Net debt / EBITDANet cash (TTM to Jun 30, 2026) 100 15%
Interest coverageInterest coverage 26.1x (TTM to Jun 30, 2026) 100 10%
Dividend record37 years of uninterrupted regular payments 98 20%
Earnings stabilityNet income positive in 5 of the last 5 fiscal years (FY2022–FY2026) 100 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

How the Dividend Growth Score is built for OPHLF
Dividend Growth Score inputs, points and weights
InputValuePointsWeight
5-year dividend growth5-year dividend CAGR 5.0% (2020–2025) 72 25%
Consecutive annual increases0 consecutive annual increases (through 2025) 10 20%
Payout headroomHeadroom from the earnings payout ratio 49% (TTM to Jun 30, 2026) 86 20%
Earnings per share growth (3 years)EPS CAGR -13.6% (FY2023–FY2026) 0 15%
Revenue growth (3 years)Revenue CAGR 5.1% (FY2023–FY2026) 82 10%
10-year dividend growth10-year dividend CAGR 6.0% (2015–2025) 78 10%

Inputs that are not available are left out and the remaining weights are scaled up. Profile: ordinary company. Formula version 2026-10-19.4.

Key Metrics

Current Yield

3.59%

At the Oct 30, 2026 price

The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.

Annualized Dividend

$0.5058

Declared May 08, 2026

The latest declared regular dividend scaled to a full year by how often it's paid (for semi-annual payers, the latest two payments), adjusted for stock splits. A $0.25 quarterly dividend annualizes to $1.00. Special dividends are excluded.

Frequency

S Semi-Annual

How often the dividend is paid, read from the dates of recent payments: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.

RSI (14)

34

As of Oct 30, 2026

Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.

52-Week Range

$11.08 – $18.67

Closes through Oct 23, 2026

The lowest and highest price over the past year, showing where today's price sits in its recent range.

Payout Ratio (TTM)

49.26%

12 months to Jun 30, 2026 (Q1 FY2027)

The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.

Years Paying

38

How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.

Price / Book (TTM)

1.35

Price as of Oct 25, 2026; latest reported book value

Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.

S.A.F.E. Dividend Read

S.A.F.E. is a set of four checks on a dividend's record and the company's data, the same test used across the screener and our ranked lists. Solid: a Dividend Safety Score of 70+ and a yield of 2%+. Accelerating: at least three consecutive completed calendar years of higher total regular dividends. Flawless: since 1990, no calendar year whose total regular dividend fell more than 20% below the year before, and no suspension. Enduring: at least 20 years between the first and latest dividend in our records. All four met earns the S.A.F.E. flag.
S Solid
Meets the Solid check: Dividend Safety Score 98/100 and yield 3.59%.
A Accelerating
Dividend growth has stalled — 0 consecutive annual increase(s), under the 3 this check looks for.
F Flawless
A calendar year's regular dividend total fell more than 20% below the year before.
E Enduring
38 years of dividend payments on record.

Quote & Key Data

ExchangeOther OTCThe stock exchange where the shares trade, such as NYSE or Nasdaq.
Volume625Oct 23, 2026 sessionHow many shares changed hands in the trading session dated beside this figure, a rough read on trading activity. Daily bars are refreshed on a slower cycle than the quoted price, so this session can be older than the price above.
Open$15.16Oct 23, 2026 sessionThe price at the start of the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Day Range$15.16 – $15.16Oct 23, 2026 sessionThe lowest and highest price during the trading session dated beside this figure, which can be earlier than the session the quoted price comes from.
Prev Close$15.16Close of Oct 22, 2026The closing price from the session before the one dated beside these figures.
Market Cap$6.63BAs of Oct 30, 2026The company's total market value (share price times shares outstanding) on the date shown.
Shares Out469.91MImplied by market cap, Oct 30, 2026Shares outstanding implied by the market cap and share price on the date shown.
EPS (TTM)JPY 162.4312 months to Jun 30, 2026 (Q1 FY2027); reported in JPYEarnings per share over the trailing twelve months (TTM), labeled with the end date of the latest reported quarter and shown in the company's reporting currency. Dividends are paid out of these earnings.
P/E (TTM)15.4Price as of Oct 25, 2026; earnings to Jun 30, 2026Price-to-earnings ratio: the share price on the date shown divided by trailing-twelve-month earnings per share. A rough gauge of how richly the stock is valued.
Last Ex-DateSep 30, 2026The most recent ex-dividend date that has already passed.
Next Ex-DateN/ANone declared yetThe ex-dividend date of the next payment the company has declared, or that is scheduled when no declaration is on file. Future dates our data provider only projects are not shown.

Dividend Growth

3-Yr Growth (CAGR)5.4%Annual totals, 2022–2025The dividend's average annual growth rate over the period, compounded.
5-Yr Growth (CAGR)5.0%Annual totals, 2020–2025The dividend's average annual growth rate over the period, compounded.
Consecutive Increases0 yrsAnnual totals through 2025The number of consecutive years the dividend has increased.

How often a record like this ends in a cut

Years the payout rose21Since Nov 1988
Rank among payers412of 2,430 with a record
Years it fell over 20%1in 37 comparable years
Of peers with 10 to 24 up years75%also cut at some point

OPHLF has raised its annual dividend in 21 separate years since November 1988, which ranks 412 among the 2,430 payers with a comparable record in our dataset. In 1 year the annual total fell by more than a fifth.

Of the 878 companies we track with 10 to 24 years of increases, 661 — 75 per cent — also have at least one year in which the dividend fell by more than 20 per cent. Across every company with twenty years of comparable history, only 277 of 1078 (26 per cent) have never cut. A long record of increases is common; a record with no cut anywhere in it is not.

Measured from annual totals using split-adjusted amounts, comparing only consecutive years with the same number of payments — a stock split and a payment shifting across a year boundary both look like cuts otherwise. The current year is excluded as incomplete. How we measure a cut, and what the corrections change. Figures are for information only, not a view on any security.

Why the Yield Moved (90 Days)

OPHLF's dividend yield rose from 3.40% to 3.59% over the past ~90 days (+0.18 pp). Of that move, +0.00 pp came from changes in the dividend rate and +0.18 pp from the share price ($14.86 on Aug 03, 2026 → $14.10 on Oct 30, 2026). A yield that rises because the price fell is not an improvement in the payout itself.

Yield vs Its Own History

Current3.59%
1-Yr Average3.60%
Low / High2.79% – 5.04%
Percentile61%

Across 272 daily observations over the past 13 months (through Oct 23, 2026), OPHLF's current yield is higher than approximately 61% of them. Our stored price history for OPHLF covers the past 13 months; 3- and 5-year averages are not yet computable from it and are deliberately not shown.

Adjusted Price History

Dividend History

Dividend Payment History

Ex-dividend calendar →
Amount Type Declared Ex-Date Record Pay
$0.2544 S Regular May 08, 2026 Sep 30, 2026 Sep 30, 2026 N/A
$0.2518 S Regular N/A Sep 29, 2026 Sep 30, 2026 Sep 29, 2026
$0.2514 S Regular May 08, 2025 Mar 31, 2026 Mar 31, 2026 Jun 19, 2026
$0.2703 S Regular May 08, 2025 Sep 30, 2025 Sep 30, 2025 Dec 01, 2025
$0.2668 S Regular May 09, 2024 Mar 31, 2025 Mar 31, 2025 Jun 20, 2025
$0.2792 S Regular May 09, 2024 Sep 30, 2024 Sep 30, 2024 Dec 02, 2024
$0.2643 S Regular May 10, 2023 Mar 28, 2024 Mar 31, 2024 Jun 21, 2024
$0.2677 S Regular May 10, 2023 Sep 28, 2023 Sep 30, 2023 Dec 01, 2023
$0.2788 S Regular May 11, 2022 Mar 30, 2023 Mar 31, 2023 Jun 23, 2023
$0.2285 S Regular May 11, 2022 Sep 29, 2022 Sep 30, 2022 Dec 01, 2022
$0.2296 S Regular May 11, 2021 Mar 30, 2022 Mar 31, 2022 Jun 24, 2022
$0.2504 S Regular May 11, 2021 Sep 29, 2021 Sep 30, 2021 Dec 01, 2021
$0.2496 S Regular May 12, 2020 Mar 30, 2021 Mar 31, 2021 Jun 18, 2021
$0.2129 S Regular May 12, 2020 Sep 29, 2020 Sep 30, 2020 Dec 01, 2020
$0.2082 S Regular May 09, 2019 Mar 30, 2020 Mar 31, 2020 Jun 19, 2020
$0.2082 S Regular May 09, 2019 Sep 27, 2019 Sep 30, 2019 Dec 02, 2019
$0.2038 S Regular N/A Mar 27, 2019 Mar 31, 2019 Jun 21, 2019
$0.1992 S Regular N/A Sep 26, 2018 Sep 30, 2018 Dec 03, 2018
$0.1882 S Regular N/A Mar 28, 2018 Mar 31, 2018 Jun 25, 2018
$0.2217 S Regular N/A Sep 27, 2017 Sep 30, 2017 Dec 01, 2017
$0.1801 S Regular N/A Mar 29, 2017 Mar 31, 2017 Jun 30, 2017
$0.1989 S Regular N/A Sep 28, 2016 Sep 30, 2016 Dec 01, 2016
$0.7941 S Regular N/A Mar 29, 2016 Mar 31, 2016 Jun 30, 2016
$0.7510 S Regular N/A Sep 28, 2015 Sep 30, 2015 Dec 01, 2015
$0.7553 S Regular N/A Mar 27, 2015 Mar 31, 2015 Jun 29, 2015
$0.8233 S Regular N/A Sep 26, 2014 Sep 30, 2014 Dec 01, 2014
$0.8813 S Regular N/A Mar 27, 2014 Mar 31, 2014 Jun 30, 2014
$0.9095 S Regular N/A Sep 26, 2013 Sep 30, 2013 Dec 02, 2013
$0.9536 S Regular N/A Mar 27, 2013 Mar 31, 2013 Jun 27, 2013
$1.1571 S Regular N/A Sep 26, 2012 Sep 30, 2012 Dec 03, 2012
$1.0877 S Regular N/A Mar 28, 2012 Mar 31, 2012 Jun 29, 2012
$1.1763 S Regular N/A Sep 28, 2011 Sep 30, 2011 Dec 01, 2011
$1.0924 S Regular N/A Mar 29, 2011 Mar 31, 2011 Jun 30, 2011
$1.0737 S Regular N/A Sep 28, 2010 Sep 30, 2010 Dec 01, 2010
$0.9713 S Regular N/A Mar 29, 2010 Mar 31, 2010 Jun 30, 2010
$1.0018 S Regular N/A Sep 25, 2009 Sep 30, 2009 Dec 01, 2009
$0.9107 S Regular N/A Mar 26, 2009 Mar 31, 2009 Jun 29, 2009
$0.8464 S Regular N/A Sep 25, 2008 Sep 30, 2008 Dec 01, 2008
$1.1316 S Regular N/A Mar 26, 2008 Mar 31, 2008 Jun 30, 2008
$0.7848 S Regular N/A Sep 25, 2007 Sep 30, 2007 Dec 03, 2007
$0.5082 S Regular N/A Mar 27, 2007 Mar 31, 2007 Jun 29, 2007
$0.6851 A Regular N/A Mar 28, 2006 Mar 31, 2006 Jun 30, 2006
$0.6077 A Regular N/A Mar 28, 2005 Mar 31, 2005 Jun 30, 2005
$0.4238 A Regular N/A Mar 26, 2004 Mar 31, 2004 Jun 30, 2004
$0.3329 A Regular N/A Mar 26, 2003 Mar 31, 2003 Jun 30, 2003
$0.2549 A Regular N/A Mar 26, 2002 Mar 31, 2002 Jun 28, 2002
$0.2771 A Regular N/A Mar 27, 2001 Mar 31, 2001 Jun 29, 2001
$0.3186 A Regular N/A Mar 28, 2000 Mar 31, 2000 Jun 30, 2000
$30.0000 A Regular N/A Mar 26, 1999 Mar 31, 1999 Jun 30, 1999
$28.0000 A Regular N/A Mar 26, 1998 Mar 31, 1998 Jun 29, 1998
$28.0000 A Regular N/A Mar 26, 1997 Mar 31, 1997 Jun 30, 1997
$28.0000 A Regular N/A Mar 26, 1996 Mar 31, 1996 Jun 28, 1996
$27.0000 A Regular N/A Mar 28, 1995 Mar 31, 1995 Jun 30, 1995
$25.0000 A Regular N/A Mar 28, 1994 Mar 31, 1994 Jun 30, 1994
$20.0000 A Regular N/A Mar 26, 1993 Mar 31, 1993 Jun 30, 1993
$14.0000 A Regular N/A Mar 26, 1992 Mar 31, 1992 Jun 29, 1992
$13.5000 A Regular N/A Mar 26, 1991 Mar 31, 1991 Jun 28, 1991
$4.0000 A Special N/A Mar 27, 1990 Mar 31, 1990 Jun 29, 1990
$12.0000 A Regular N/A Nov 27, 1989 Nov 30, 1989 Feb 28, 1990
$12.0000 A Regular N/A Nov 26, 1988 N/A Mar 16, 1989

1 future payment listed by our data provider without a declaration is a projection, so it is not listed here or shown as a last or next dividend.

Peer Comparison

Selected Drug Manufacturers - General dividend payers we cover, strongest DividendRank first — for context, not a recommendation.

TickerNameYield5-Yr GrowthStreakRank
ZTS Zoetis Inc. 2.69% 20.1% 11 yrs 94
BMY Bristol-Myers Squibb Company 4.10% 6.6% 18 yrs 86
ALPMY Astellas Pharma Inc. 3.10% 5.6% 11 yrs 80
ALPMF Astellas Pharma Inc. 2.87% 5.9% 3 yrs 80

OPHLF dividend — frequently asked questions

Does Ono Pharmaceutical Co., Ltd. pay a dividend?

Yes. Ono Pharmaceutical Co., Ltd. (OPHLF) currently pays a dividend. The annualized dividend is about $0.51 per share, a yield of approximately 3.59%.

What is Ono Pharmaceutical Co., Ltd.'s dividend yield?

Ono Pharmaceutical Co., Ltd.'s dividend yield is approximately 3.59%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.

How often does Ono Pharmaceutical Co., Ltd. pay dividends?

Ono Pharmaceutical Co., Ltd. pays dividends semi-annually — 2 times per year.

How long has Ono Pharmaceutical Co., Ltd. paid dividends?

Ono Pharmaceutical Co., Ltd. has 38 years of dividend payments on record.

Data updated Oct 30, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.